Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is an Acquisition of Acceleron a Smart Move for Merck?

TheMotleyFool

0 0

Is an Acquisition of Acceleron a Smart Move for Merck?

First, there were rumors that Merck (NYSE: MRK) might acquire Acceleron Pharma (NASDAQ: XLRN). Then those rumors were confirmed, with the big pharma company announcing plans to buy Acceleron for $11.5 billion. In this Motley Fool Live video recorded on Sept. 29, 2021 (one day before Merck's announcement of the deal), Motley Fool contributors Keith Speights and Brian Orelli discuss whether acquiring Acceleron would be a smart move for Merck.

Source Fool.com

Like: 0

MRK

Share